NewcelX Ltd.
PublicNewcelX Ltd. is now publicly traded
The data on this page reflects NewcelX Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Aug 24, 2026
Total Funding Raised
$6.37M
Company Overview
NewcelX Ltd. is a biotechnology company that develops transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
regenerative medicinecell therapyhuman pluripotent stem cellhPSCbiopharmaceuticaldrug discoveryislet replacement therapyclinical-stage biotechsmall-molecule treatmentneurodegenerative diseasemetabolic diseaseoff-the-shelf therapybiotech startupclinical trialsALS treatment
NewcelX Ltd. Comparables
Compare NewcelX Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caspian Therapeutics, Inc. | 71% |
NewcelX Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 24, 2026 | ||||
| Private Placement | May 13, 2026 |
Key People
Founding team and executive leadership
NewcelX Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
HeadquartersSwitzerland
Employee Range28
Year Founded2025
Last FundingAug 24, 2026
See something wrong or outdated?